Back to search

United States· US:43598-827_8a130978-3a2c-2fe5-ba95-8b008140068d

Eye Allergy Itch Relief

A olopatadine product containing olopatadine hydrochloride, registered in United States by Dr. Reddy's Laboratories Inc.. The same ATC class is registered in 13 of our 19 countries.

ATC S01GX09US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedEye Allergy Itch ReliefATCS01GX09REGISTER NO.US:43598-827_8a130978…PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Olopatadine is registered in 13 of 19 countries.

Countries holding a registration under ATC S01GX09 (olopatadine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Olopatadine · ATC S01GX09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OLOPATADINE HYDROCHLORIDE
Manufacturer
Dr. Reddy's Laboratories Inc.
Country
United States (US)
ATC code
S01GX09
ATC class
Olopatadine
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    4359882702
    1 BOTTLE, PLASTIC in 1 CARTON (43598-827-02) / 2.5 mL in 1 BOTTLE, PLASTIC
  • ndc11
    4359882725
    2 BOTTLE, PLASTIC in 1 CARTON (43598-827-25) / 2.5 mL in 1 BOTTLE, PLASTIC
  • ndc11
    43598-827-02
  • ndc11
    43598-827-25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

142 interactions on record for olopatadine.

Graded by severity as the source publishes them — 142 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olopatadine · interactions on record

142 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Olopatadine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olopatadine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Olopatadin Micro Labs, Olopatadin Unimed Pharma
  • Bulgaria · Оловижън, Олопатадин Унимед Фарма
  • Cyprus · Alopatan, Olopatadine Rafarm
  • Czechia · Olopatadine Unimed Pharma, Olopatidine Olikla
  • Germany · Alltrevo, Olopatadin Actrevo
  • Denmark · Olopatadin Brown & Burk, Olopatadin Juta
  • Estonia · Olopatadine Unimed Pharma
  • Spain · Apadin, Olopatadina Abamed
  • United Kingdom (Northern Ireland) · Olopatadine Blumont Pharma, Olopatadine Brown & Burk Uk
  • Greece · Alopatan, Olopatadine Rafarm
  • Croatia · Olopatadin
  • Hungary · Olopatadine Unimed Pharma
  • Ireland · Olopatadine Brown & Burk
  • Iceland · Opatanol
  • Italy · Calmira®, Olonet
  • Liechtenstein · Opatanol
  • Lithuania · Olopatadine Unimed Pharma
  • Latvia · Olopatadine Unimed Pharma
  • Malta · Olopatadine Unimed Pharma
  • Netherlands · Olopatadine Brown & Burk, Optamont
  • Norway · Olopatadine Sandoz, Opatanol
  • Poland · Oftahist, Olodon Free
  • Portugal · Olopatadina Stallpharma
  • Romania · Olopatadina Brown & Burk, Olopatadină Rompharm
  • Sweden · Olopatadin Evolan, Olopatadin Orifarm
  • Slovenia · Olopatadin Unimed Pharma
  • Slovakia · Olopatadine Olikla, Olopatadine Unimed Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ab8181a5-1970-4550-b890-d95e72b5efb1
GET /v1/drugs/ab8181a5-1970-4550-b890-d95e72b5efb1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": "2",
  "substance": "OLOPATADINE HYDROCHLORIDE",
  "productndc": "43598-827",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA209752",
  "marketing_category": "ANDA"
}

See everything about olopatadine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.